Expertise in
2
conditions

Dr. Mark D. Blostein

3755 Chemin De La Cote Ste Cat, Jewish General Hospital, 
Montreal, QC, CA 
Expertise in
2
conditions
3755 Chemin De La Cote Ste Cat, Jewish General Hospital, 
Montreal, QC, CA 

Overview

Mark Blostein practices practicing medicine in Montreal, Canada.

Dr. Blostein is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Deep Vein Thrombosis, Mesenteric Venous Thrombosis, Adult Immune Thrombocytopenia, and Immune Thrombocytopenic Purpura (ITP).

He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 5 clinical trials.

Licenses

Pathology in MA

Languages Spoken

English

Gender

Male

Locations

3755 Chemin De La Cote Ste Cat, Jewish General Hospital, Montreal, QC H3T1E2, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HIT
Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HIT
Enrollment Status: Terminated
Publish Date: December 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Enrollment Status: Completed
Publish Date: September 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).
Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).
Enrollment Status: Completed
Publish Date: June 28, 2019
Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis
Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis
Enrollment Status: Completed
Publish Date: October 18, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

39 Total Publications

Extracellular RNA Induces Neutrophil Recruitment Via Toll-Like Receptor 3 During Venous Thrombosis After Vascular Injury.
Extracellular RNA Induces Neutrophil Recruitment Via Toll-Like Receptor 3 During Venous Thrombosis After Vascular Injury.
Journal: Journal of the American Heart Association
Published: July 19, 2024

Frequently Asked Questions about Dr. Mark D. Blostein

How do I make an appointment with Dr. Mark D. Blostein?

You can book an appointment with Dr. Mark D. Blostein by calling their office at 514-340-8207. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark D. Blostein a top-rated expert for Deep Vein Thrombosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark D. Blostein is classified as an Advanced expert for Deep Vein Thrombosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dr. Mark D. Blostein participate in research or clinical trials?

Yes. Dr. Mark D. Blostein has published 39 articles and abstracts on conditions like Deep Vein Thrombosis. You can view a list of Dr. Mark D. Blostein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Blostein's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile